TRANSGENE S.A.

Patent Owner

Follow Compare

Stats

Details

Technologies

Intl Class Technology # of Patents Rank
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4775
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 33161
 
 
 
C07K PEPTIDES 1078
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 785
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 666
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 572
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 287
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 141
 
 
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 171

Top Patents (by citation)

Patent # Title Filing Date Issue Date Intl Class Cited #
6,040,174 Defective adenoviruses and corresponding complementation linesJan 26, 95Mar 21, 00[C12N]45
6,013,638 Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lungDec 13, 93Jan 11, 00[C12N, A61K]29
6,110,735 Method for the preparation of a viral vector by intermolecular homologous recombinationAug 01, 96Aug 29, 00[C12N, C07H, A61K, C07K]22
5,744,133 Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumorDec 15, 94Apr 28, 98[C12N, A01N]18
6,281,000 Method for the preparation of a viral vector by intermolecular homologous recombinationDec 21, 99Aug 28, 01[C12N, C07H, A61K, C07K]16
5,861,381 Pharmaceutical composition for the treatment of a malignant tumorJun 07, 95Jan 19, 99[C12N, A61K]15
6,133,028 Defective adenoviruses and corresponding complementation linesSep 30, 99Oct 17, 00[C12N]12
5,169,763 Viral vector coding glycoprotein of HIV-1Sep 24, 91Dec 08, 92[C12N, C12P]10
6,884,786 Antitumoral composition based on immunogenic polypeptide with modified cell locationApr 17, 00Apr 26, 05[C12N, C07H, A01N, A61K]9
6,136,594 Replication deficient recombinant adenovirus vectorMay 16, 95Oct 24, 00[C12N, A01N]7

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2013/0095,557 IMMORTALIZED AVIAN CELL LINESJun 29, 11Apr 18, 13[C12N]
2013/0084,620 PROCESS FOR PRODUCING POXVIRUSES AND POXVIRUS COMPOSITIONSOct 24, 11Apr 04, 13[C12N]
2013/0039,891 POXVIRAL ONCOLYTIC VECTORSSep 15, 12Feb 14, 13[C12N, A61P, A61K]
2013/0011,435 COMPOSITION FOR TREATING HBV INFECTIONAug 06, 10Jan 10, 13[C12N, A61P, A61K]
2012/0276,614 PROCESS FOR PRODUCING POXVIRUSES AND POXVIRUS COMPOSITIONSOct 24, 11Nov 01, 12[C12N]
2012/0251,569 COMPOSITION FOR TREATING HBV INFECTIONMar 17, 12Oct 04, 12[C12N, A61P, A61K, C07K]
2012/0238,000 IMMORTALIZED AVIAN CELL LINESMay 29, 12Sep 20, 12[C12N]
2012/0190,100 ENZYMATIC COMPOSITION FOR THE DIGESTION OF CHICKEN EMBRYOSJul 21, 10Jul 26, 12[C12N, C12S]
2012/0122,155 IMMORTALIZED AVIAN CELL LINES AND USE THEREOFMay 11, 10May 17, 12[C12N, C12P]
2012/0115,249 Biomarker for Selecting Patients and Related MethodsJul 06, 10May 10, 12[G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,420,103 Papillomavirus vaccinesJan 29, 08Apr 16, 13[C12N, A61P, A61K]
8,415,133 Process for producing poxviruses and poxvirus compositionsOct 24, 11Apr 09, 13[C12N]
8,415,134 Process for producing poxviruses and poxvirus compositionsOct 24, 11Apr 09, 13[C12N]
8,415,462 Signaling peptidesJan 29, 08Apr 09, 13[C12N, C07H, C12P, C12Q]
8,361,788 Immortalized avian cell lines comprising E1A nucleic acid sequencesJul 02, 08Jan 29, 13[C12N]
8,357,531 Immortalized avian cell linesJul 02, 10Jan 22, 13[C12N, C12P]
8,337,859 Vectors for multiple gene expressionJan 29, 08Dec 25, 12[C12N, A61K]
8,293,528 Peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virusDec 17, 09Oct 23, 12[C12N, A48K]
8,257,692 Polypeptide having an improved cytosine deaminase activityJun 24, 10Sep 04, 12[A01N, A61K]
8,226,954 Polypeptide having an improved cytosine deaminase activityJun 24, 10Jul 24, 12[C07H, C12P, A61K, C07K]

View all patents..

Top Inventors for This Owner

Inventor Name Address # of Patent/Pub
Erbs Philippe
Strasbourg, FR
24
Mehtali Majid
Amsterdam, NL
21
Kieny Marie-Paule
Strasbourg, FR
20
Silvestre Nathalie
Egersheim, FR
19
Balloul Jean-Marc
Lingolsheim, FR
15
Fournillier Anne
Villeurbanne, FR
14
Sene Claude
Not Provided
12
Kapfer Marina
Not Provided
11
Acres Bruce
Strasbourg, FR
10